[Protective effect of anticholinesterase agents on protein and RNA concentrations in the supraoptic nucleus of the brain during deprivation of the paradoxical stage of sleep].
D000818:Animals; D001138:Armin / Q000494:pharmacology*; D006651:Histocytochemistry; D007031:Hypothalamus / Q000187:drug effects*; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009457:Neuroglia / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D009943:Organophosphorus Compounds / Q000494:pharmacology*; D009946:Organothiophosphorus Compounds / Q000494:pharmacology*; D012313:RNA / Q000378:metabolism; D051381:Rats; D012892:Sleep Deprivation; D012895:Sleep, REM / Q000187:drug effects*; D013495:Supraoptic Nucleus / Q000187:drug effects* / Q000378:metabolism
D009419:Nerve Tissue Proteins; D009943:Organophosphorus Compounds; D009946:Organothiophosphorus Compounds; D012313:RNA; D001138:Armin
Zashchitnoe deĭstvie antikholinésteraznykh agentov na soderzhanie belkov i RNK v supraopticheskom iadre golovnogo mozga pri lishenii paradoksal'noĭ fazy sna.